142 related articles for article (PubMed ID: 38387943)
1. [Research Progress on the Application Strategies of Plerixafor in the Peripheral Blood Stem Cell Mobilization for Autologous Transplantation--Review].
Fang Y; Ye PP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):322-326. PubMed ID: 38387943
[TBL] [Abstract][Full Text] [Related]
2. Successful Mobilization of Autologous Hematopoietic Peripheral Blood Stem Cells after Salvage Chemotherapy in Patients with Low CD34 Blood Cell Counts.
Holmberg LA; Linenberger M; Connelly-Smith L
Transplant Cell Ther; 2022 Nov; 28(11):754-759. PubMed ID: 36002104
[TBL] [Abstract][Full Text] [Related]
3. Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.
Ishii A; Jo T; Arai Y; Oshima S; Kanda J; Kitawaki T; Matsui K; Niwa N; Nakagawa Y; Takaori-Kondo A; Nagao M
Cytotherapy; 2022 Jan; 24(1):49-58. PubMed ID: 34654641
[TBL] [Abstract][Full Text] [Related]
4. Autologous peripheral blood stem cell mobilization and collection in patients with lymphoma and multiple myeloma: A single-center experience using the plerixa for pre-emptive approach.
Alsaeed AS; Najib MJ; Al Amoudi SM; Elhemaidi IY; Absi AA; Al Ahmadi MD; Eldadah SK; Rajkhan WA; Khalil MM; Almohammadi MH
Saudi Med J; 2022 Jun; 43(6):626-632. PubMed ID: 35675941
[TBL] [Abstract][Full Text] [Related]
5. EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
Karres D; Ali S; van Hennik PB; Straus S; Josephson F; Thole G; Glerum PJ; Herberts C; Babae N; Herold R; Papadouli I; Pignatti F
Oncologist; 2020 Jun; 25(6):e976-e981. PubMed ID: 32154610
[TBL] [Abstract][Full Text] [Related]
6. Third time's a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor.
Zhuang L; Boriboonnangkul P; Wang S; Yuan S
Transfusion; 2020 Jun; 60(6):1253-1259. PubMed ID: 32483875
[TBL] [Abstract][Full Text] [Related]
7. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.
Hartmann T; Hübel K; Monsef I; Engert A; Skoetz N
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010615. PubMed ID: 26484982
[TBL] [Abstract][Full Text] [Related]
8. Impact of Plerixafor Use at Different Peripheral Blood CD34
Shah EE; Young RP; Wong SW; Damon LE; Wolf JL; Shah ND; Leavitt AD; Loeffler P; Martin TG
Biol Blood Marrow Transplant; 2020 May; 26(5):876-883. PubMed ID: 31785375
[TBL] [Abstract][Full Text] [Related]
9. [A Single-Center Analysis of the Use of G-CSF Combined with Plerixafor to Mobilize Peripheral Blood Hematopoietic Stem Cell from Healthy Related Donors in Allogeneic Hematopoietic Stem Cell Transplantation].
Chen J; Yuan LL; Zhang X; Qiao JL; Yin QX; Zhang YM; Yang XL; Cao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):286-291. PubMed ID: 35123641
[TBL] [Abstract][Full Text] [Related]
10. First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients.
Bekadja MA; Mansour B; Ouldjeriouat H; Entasoltan B; Bouchama S; Charef L; Amani K; Hakiki N; Bouamama F; Osmani S; Brahimi M; Arabi A; Bouhass R; Yafour N
Transfus Apher Sci; 2021 Jun; 60(3):103070. PubMed ID: 33612450
[TBL] [Abstract][Full Text] [Related]
11. Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor.
Uchida N; Leonard A; Stroncek D; Panch SR; West K; Molloy E; Hughes TE; Hauffe S; Taylor T; Fitzhugh C; Hankins JS; Wilson M; Sharma A; Tsai SQ; Weiss MJ; Hsieh M; Tisdale JF
Haematologica; 2020 Oct; 105(10):e497. PubMed ID: 33054091
[No Abstract] [Full Text] [Related]
12. Addition of plerixafor in poorly mobilized allogeneic stem cell donors.
Zhuang L; Lauro D; Wang S; Yuan S
J Clin Apher; 2022 Aug; 37(4):388-394. PubMed ID: 35633513
[TBL] [Abstract][Full Text] [Related]
13. Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/-plerixafor vs cyclophosphamide/GCSF+/-plerixafor.
Yang C; Dehghani M; Hopman W; Bhella S
J Clin Apher; 2022 Aug; 37(4):348-353. PubMed ID: 35218068
[TBL] [Abstract][Full Text] [Related]
14. Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients.
Teusink A; Pinkard S; Davies S; Mueller M; Jodele S
Transfusion; 2016 Jun; 56(6):1402-5. PubMed ID: 27079854
[TBL] [Abstract][Full Text] [Related]
15. Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant.
Fergadis E; Assi A; Kranidioti E; Kosma A; Karakosta M; Miltiadous C; Dimitriadis GK; Grivas A; Athanasopoulos A; Lianos E; Kosmas C
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e50-e57. PubMed ID: 31884151
[TBL] [Abstract][Full Text] [Related]
16. Successful "on-demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors.
Corbingi A; Metafuni E; Di Salvatore M; Putzulu R; Chiusolo P; Schinzari G; Massini G; Rossi E; Zini G; Cassano A; Sica S; Piccirillo N
J Clin Apher; 2022 Feb; 37(1):65-69. PubMed ID: 34822725
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection.
Cashen AF; Rettig M; Gao F; Smith A; Abboud C; Stockerl-Goldstein K; Vij R; Uy G; Westervelt P; DiPersio J
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1282-1289. PubMed ID: 28476490
[TBL] [Abstract][Full Text] [Related]
18. Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors.
Romon I; Castillo C; Cid J; Lozano M
Vox Sang; 2022 Jan; 117(1):6-16. PubMed ID: 34159611
[TBL] [Abstract][Full Text] [Related]
19. UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.
Douglas KW; Gilleece M; Hayden P; Hunter H; Johnson PRE; Kallmeyer C; Malladi RK; Paneesha S; Pawson R; Quinn M; Raj K; Richardson D; Robinson S; Russell N; Snowden J; Sureda A; Tholouli E; Thomson K; Watts M; Wilson KM
J Clin Apher; 2018 Feb; 33(1):46-59. PubMed ID: 28631842
[TBL] [Abstract][Full Text] [Related]
20. Threshold for optimal administration of plerixafor in autologous peripheral blood stem cell collections through CD34+ cell monitoring based on the experience from two Japanese university hospitals.
Okubo M; Furuta Y; Nakamura Y; Osawa T; Tada N; Sawada T; Yamatoya K; Sekiguchi Y; Araki Y; Miyake K; Noguchi M; Komatsu N; Ohsaka A
Ther Apher Dial; 2021 Oct; 25(5):687-696. PubMed ID: 33325621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
